Esser KM - Search Results

1

Cardiovascular and pulmonary effects of human recombinant tumor necrosis factor in the conscious rat.

Turner CR, Esser KM, Wheeldon EB, Slivjak M, Smith EF 3rd. Turner CR, et al. Among authors: esser km. Circ Shock. 1989 Aug;28(4):369-84. Circ Shock. 1989. PMID: 2673572

2

Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.

Rabinovici R, Yue TL, Farhat M, Smith EF 3rd, Esser KM, Slivjak M, Feuerstein G. Rabinovici R, et al. Among authors: esser km. J Pharmacol Exp Ther. 1990 Oct;255(1):256-63. J Pharmacol Exp Ther. 1990. PMID: 2213560

3

Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition.

Turner CR, Esser KM, Wheeldon EB. Turner CR, et al. Among authors: esser km. Circ Shock. 1993 Mar;39(3):237-45. Circ Shock. 1993. PMID: 8384094

4

Fluid resuscitation improves survival of endotoxemic or septicemic rats: possible contribution of tumor necrosis factor.

Smith EF 3rd, Slivjak MJ, Egan JW, Gagnon R, Arleth AJ, Esser KM. Smith EF 3rd, et al. Among authors: esser km. Pharmacology. 1993 May;46(5):254-67. doi: 10.1159/000139053. Pharmacology. 1993. PMID: 8488170

5

SK&F 86002 inhibits tumor necrosis factor formation and improves survival in endotoxemic rats.

Smith EF 3rd, Slivjak MJ, Bartus JO, Esser KM. Smith EF 3rd, et al. Among authors: esser km. J Cardiovasc Pharmacol. 1991 Nov;18(5):721-8. doi: 10.1097/00005344-199111000-00010. J Cardiovasc Pharmacol. 1991. PMID: 1723769

6

Adjuvant arthritic (AA) rats exhibit enhanced endotoxin-induced plasma TNF (EIPT) levels.

DiMartino M, Slivjak M, Esser K, Wolff C, Smith E 3rd, Gagnon R. DiMartino M, et al. Agents Actions. 1993;39 Spec No:C58-60. doi: 10.1007/BF01972720. Agents Actions. 1993. PMID: 8273587

7

Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.

Prabhakar U, Lipshutz D, Bartus JO, Slivjak MJ, Smith EF 3rd, Lee JC, Esser KM. Prabhakar U, et al. Among authors: esser km. Int J Immunopharmacol. 1994 Oct;16(10):805-16. doi: 10.1016/0192-0561(94)90054-x. Int J Immunopharmacol. 1994. PMID: 7843852

8

Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock.

Olivera DL, Esser KM, Lee JC, Greig RG, Badger AM. Olivera DL, et al. Among authors: esser km. Circ Shock. 1992 Aug;37(4):301-6. Circ Shock. 1992. PMID: 1446388

9

Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.

Badger AM, Olivera DL, Esser KM. Badger AM, et al. Among authors: esser km. Circ Shock. 1994 Dec;44(4):188-95. Circ Shock. 1994. PMID: 7628060

10

Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats.

Rabinovici R, Bugelski PJ, Esser KM, Hillegass LM, Griswold DE, Vernick J, Feuerstein G. Rabinovici R, et al. Among authors: esser km. J Pharmacol Exp Ther. 1993 Dec;267(3):1550-7. J Pharmacol Exp Ther. 1993. PMID: 8263817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters